% alzhub.org library filter
% Source: https://alzhub.org/research?author=Hansson+O&access=free
% 39 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{buddhaeberlein2022-35542991,
  author  = {Budd Haeberlein, S. and Aisen, P. S. and Barkhof, F. and Chalkias, S. and Chen, T. and Cohen, S. and Dent, G. and Hansson, O. and others},
  title   = {{Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2022},
  doi     = {10.14283/jpad.2022.30},
  pmid    = {35542991},
  url     = {https://doi.org/10.14283/jpad.2022.30}
}

@article{cummings2025-39780249,
  author  = {Cummings, J. L. and Atri, A. and Feldman, H. H. and Hansson, O. and Sano, M. and Knop, F. K. and Johannsen, P. and León, T. and others},
  title   = {{evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2025},
  doi     = {10.1186/s13195-024-01666-7},
  pmid    = {39780249},
  url     = {https://doi.org/10.1186/s13195-024-01666-7}
}

@article{lu2025-41082199,
  author  = {Lu, M. and Kim, M. J. and Collins, E. C. and Shcherbinin, S. and Ellinwood, A. K. and Yokoi, Y. and Brooks, D. A. and Hansson, O. and others},
  title   = {{Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ 2 Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2025.3869},
  pmid    = {41082199},
  url     = {https://doi.org/10.1001/jamaneurol.2025.3869}
}

@article{coughlan2025-40029638,
  author  = {Coughlan, G. T. and Klinger, H. M. and Boyle, R. and Betthauser, T. J. and Binette, A. P. and Christenson, L. and Chadwick, T. and Hansson, O. and others},
  title   = {{Sex Differences in Longitudinal Tau-PET in Preclinical Alzheimer Disease: A Meta-Analysis}},
  journal = {JAMA neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2025.0013},
  pmid    = {40029638},
  url     = {https://doi.org/10.1001/jamaneurol.2025.0013}
}

@article{rabinovici2025-39776249,
  author  = {Rabinovici, G. D. and Knopman, D. S. and Arbizu, J. and Benzinger, T. L. S. and Donohoe, K. J. and Hansson, O. and Herscovitch, P. and Kuo, P. H. and Lingler, J. H. and Minoshima, S. and others},
  title   = {{Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup}},
  journal = {Alzheimer's \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.14338},
  pmid    = {39776249},
  url     = {https://doi.org/10.1002/alz.14338}
}

@article{janelidze2018-30054439,
  author  = {Janelidze, S. and Mattsson, N. and Stomrud, E. and Lindberg, O. and Palmqvist, S. and Zetterberg, H. and Blennow, K. and Hansson, O.},
  title   = {{CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease}},
  journal = {Neurology},
  year    = {2018},
  doi     = {10.1212/wnl.0000000000006082},
  pmid    = {30054439},
  url     = {https://doi.org/10.1212/wnl.0000000000006082}
}

@article{palmqvist2016-26936941,
  author  = {Palmqvist, S. and Mattsson, N. and Hansson, O. and {Alzheimer’s Disease Neuroimaging Initiative}},
  title   = {{Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography}},
  journal = {Brain : a journal of neurology},
  year    = {2016},
  doi     = {10.1093/brain/aww015},
  pmid    = {26936941},
  url     = {https://doi.org/10.1093/brain/aww015}
}

@article{collij2024-39277604,
  author  = {Collij, L. E. and Mastenbroek, S. E. and Mattsson-Carlgren, N. and Strandberg, O. and Smith, R. and Janelidze, S. and Palmqvist, S. and Ossenkoppele, R. and Hansson, O.},
  title   = {{Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer's disease}},
  journal = {Nature Communications},
  year    = {2024},
  doi     = {10.1038/s41467-024-52299-1},
  pmid    = {39277604},
  url     = {https://doi.org/10.1038/s41467-024-52299-1}
}

@article{janelidze2023-36987840,
  author  = {Janelidze, S. and Barthélemy, N. R. and He, Y. and Bateman, R. J. and Hansson, O.},
  title   = {{Mitigating the Associations of Kidney Dysfunction With Blood Biomarkers of Alzheimer Disease by Using Phosphorylated Tau to Total Tau Ratios}},
  journal = {JAMA neurology},
  year    = {2023},
  doi     = {10.1001/jamaneurol.2023.0199},
  pmid    = {36987840},
  url     = {https://doi.org/10.1001/jamaneurol.2023.0199}
}

@article{cicognola2021-33773595,
  author  = {Cicognola, C. and Janelidze, S. and Hertze, J. and Zetterberg, H. and Blennow, K. and Mattsson-Carlgren, N. and Hansson, O.},
  title   = {{Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment}},
  journal = {Alzheimer's research \& therapy},
  year    = {2021},
  doi     = {10.1186/s13195-021-00804-9},
  pmid    = {33773595},
  url     = {https://doi.org/10.1186/s13195-021-00804-9}
}

@article{hansson2023-37202517,
  author  = {Hansson, O. and Blennow, K. and Zetterberg, H. and Dage, J.},
  title   = {{Blood biomarkers for Alzheimer's disease in clinical practice and trials}},
  journal = {Nature aging},
  year    = {2023},
  doi     = {10.1038/s43587-023-00403-3},
  pmid    = {37202517},
  url     = {https://doi.org/10.1038/s43587-023-00403-3}
}

@article{hansson2018-29499171,
  author  = {Hansson, O. and Seibyl, J. and Stomrud, E. and Zetterberg, H. and Trojanowski, J. Q. and Bittner, T. and Lifke, V. and Corradini, V. and others},
  title   = {{CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2018},
  doi     = {10.1016/j.jalz.2018.01.010},
  pmid    = {29499171},
  url     = {https://doi.org/10.1016/j.jalz.2018.01.010}
}

@article{chouraki2015-25217292,
  author  = {Chouraki, V. and Beiser, A. and Younkin, L. and Preis, SR. and Weinstein, G. and Hansson, O. and Skoog, I. and Lambert, J. C. and others},
  title   = {{Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2015},
  doi     = {10.1016/j.jalz.2014.07.001},
  pmid    = {25217292},
  url     = {https://doi.org/10.1016/j.jalz.2014.07.001}
}

@article{mattsson2019-31314895,
  author  = {Mattsson, N. and Palmqvist, S. and Stomrud, E. and Vogel, J. and Hansson, O.},
  title   = {{Staging β-Amyloid Pathology With Amyloid Positron Emission Tomography}},
  journal = {JAMA neurology},
  year    = {2019},
  doi     = {10.1001/jamaneurol.2019.2214},
  pmid    = {31314895},
  url     = {https://doi.org/10.1001/jamaneurol.2019.2214}
}

@article{mattssoncarlgren2020-32398359,
  author  = {Mattsson-Carlgren, N. and Leuzy, A. and Janelidze, S. and Palmqvist, S. and Stomrud, E. and Strandberg, O. and Smith, R. and Hansson, O.},
  title   = {{The implications of different approaches to define AT(N) in Alzheimer disease}},
  journal = {Neurology},
  year    = {2020},
  doi     = {10.1212/wnl.0000000000009485},
  pmid    = {32398359},
  url     = {https://doi.org/10.1212/wnl.0000000000009485}
}

@article{gertje2023-36882326,
  author  = {Gertje, E. C. and Janelidze, S. and van Westen, D. and Cullen, N. and Stomrud, E. and Palmqvist, S. and Hansson, O. and Mattsson-Carlgren, N.},
  title   = {{Associations Between CSF Markers of Inflammation, White Matter Lesions, and Cognitive Decline in Individuals Without Dementia}},
  journal = {Neurology},
  year    = {2023},
  doi     = {10.1212/wnl.0000000000207113},
  pmid    = {36882326},
  url     = {https://doi.org/10.1212/wnl.0000000000207113}
}

@article{ossenkoppele2019-30626656,
  author  = {Ossenkoppele, R. and Smith, R. and Ohlsson, T. and Strandberg, O. and Mattsson, N. and Insel, P. S. and Palmqvist, S. and Hansson, O.},
  title   = {{Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease}},
  journal = {Neurology},
  year    = {2019},
  doi     = {10.1212/wnl.0000000000006875},
  pmid    = {30626656},
  url     = {https://doi.org/10.1212/wnl.0000000000006875}
}

@article{berron2020-32252068,
  author  = {Berron, D. and van Westen, D. and Ossenkoppele, R. and Strandberg, O. and Hansson, O.},
  title   = {{Medial temporal lobe connectivity and its associations with cognition in early Alzheimer's disease}},
  journal = {Brain : a journal of neurology},
  year    = {2020},
  doi     = {10.1093/brain/awaa068},
  pmid    = {32252068},
  url     = {https://doi.org/10.1093/brain/awaa068}
}

@article{tangen2022-36028328,
  author  = {Tangen, G. G. and Nilsson, M. H. and Stomrud, E. and Palmqvist, S. and Hansson, O.},
  title   = {{Spatial Navigation and Its Association With Biomarkers and Future Dementia in Memory Clinic Patients Without Dementia}},
  journal = {Neurology},
  year    = {2022},
  doi     = {10.1212/wnl.0000000000201106},
  pmid    = {36028328},
  url     = {https://doi.org/10.1212/wnl.0000000000201106}
}

@article{jansen2018-29188296,
  author  = {Jansen, W. J. and Ossenkoppele, R. and Tijms, B. M. and Fagan, A. M. and Hansson, O. and Klunk, W. E. and van der Flier, W. M. and Villemagne, V. L. and others},
  title   = {{Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia}},
  journal = {JAMA psychiatry},
  year    = {2018},
  doi     = {10.1001/jamapsychiatry.2017.3391},
  pmid    = {29188296},
  url     = {https://doi.org/10.1001/jamapsychiatry.2017.3391}
}

@article{mattsson2012-22302554,
  author  = {Mattsson, N. and Rosén, E. and Hansson, O. and Andreasen, N. and Parnetti, L. and Jonsson, M. and Herukka, S. K. and van der Flier, W. M. and others},
  title   = {{Age and diagnostic performance of Alzheimer disease CSF biomarkers}},
  journal = {Neurology},
  year    = {2012},
  doi     = {10.1212/wnl.0b013e3182477eed},
  pmid    = {22302554},
  url     = {https://doi.org/10.1212/wnl.0b013e3182477eed}
}

@article{ossenkoppele2022-35643092,
  author  = {Ossenkoppele, R. and van der Kant, R. and Hansson, O.},
  title   = {{Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials}},
  journal = {The Lancet. Neurology},
  year    = {2022},
  doi     = {10.1016/s1474-4422(22)00168-5},
  pmid    = {35643092},
  url     = {https://doi.org/10.1016/s1474-4422(22)00168-5}
}

@article{tideman2022-35022305,
  author  = {Tideman, P. and Stomrud, E. and Leuzy, A. and Mattsson-Carlgren, N. and Palmqvist, S. and Hansson, O. and {Alzheimer's Disease Neuroimaging Initiative}},
  title   = {{Association of β-Amyloid Accumulation With Executive Function in Adults With Unimpaired Cognition}},
  journal = {Neurology},
  year    = {2022},
  doi     = {10.1212/wnl.0000000000013299},
  pmid    = {35022305},
  url     = {https://doi.org/10.1212/wnl.0000000000013299}
}

@article{hansson2006-16488378,
  author  = {Hansson, O. and Zetterberg, H. and Buchhave, P. and Londos, E. and Blennow, K. and Minthon, L.},
  title   = {{Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study}},
  journal = {The Lancet. Neurology},
  year    = {2006},
  doi     = {10.1016/s1474-4422(06)70355-6},
  pmid    = {16488378},
  url     = {https://doi.org/10.1016/s1474-4422(06)70355-6}
}

@article{grothe2018-30016411,
  author  = {Grothe, M. J. and Sepulcre, J. and Gonzalez-Escamilla, G. and Jelistratova, I. and Schöll, M. and Hansson, O. and Teipel, S. J. and {Alzheimer’s Disease Neuroimaging Initiative}},
  title   = {{Molecular properties underlying regional vulnerability to Alzheimer's disease pathology}},
  journal = {Brain : a journal of neurology},
  year    = {2018},
  doi     = {10.1093/brain/awy189},
  pmid    = {30016411},
  url     = {https://doi.org/10.1093/brain/awy189}
}

@article{janelidze2016-26783546,
  author  = {Janelidze, S. and Hertze, J. and Zetterberg, H. and Landqvist Waldö, M. and Santillo, A. and Blennow, K. and Hansson, O.},
  title   = {{Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease}},
  journal = {Annals of clinical and translational neurology},
  year    = {2016},
  doi     = {10.1002/acn3.266},
  pmid    = {26783546},
  url     = {https://doi.org/10.1002/acn3.266}
}

@article{westin2012-22303443,
  author  = {Westin, K. and Buchhave, P. and Nielsen, H. and Minthon, L. and Janciauskiene, S. and Hansson, O.},
  title   = {{CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer's disease}},
  journal = {PloS one},
  year    = {2012},
  doi     = {10.1371/journal.pone.0030525},
  pmid    = {22303443},
  url     = {https://doi.org/10.1371/journal.pone.0030525}
}

@article{hansson2019-31010420,
  author  = {Hansson, O. and Lehmann, S. and Otto, M. and Zetterberg, H. and Lewczuk, P.},
  title   = {{Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer's Disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2019},
  doi     = {10.1186/s13195-019-0485-0},
  pmid    = {31010420},
  url     = {https://doi.org/10.1186/s13195-019-0485-0}
}

@article{rosen2013-23800368,
  author  = {Rosén, C. and Hansson, O. and Blennow, K. and Zetterberg, H.},
  title   = {{Fluid biomarkers in Alzheimer's disease - current concepts}},
  journal = {Molecular neurodegeneration},
  year    = {2013},
  doi     = {10.1186/1750-1326-8-20},
  pmid    = {23800368},
  url     = {https://doi.org/10.1186/1750-1326-8-20}
}

@article{zettergren2019-30792413,
  author  = {Zettergren, A. and Höglund, K. and Kern, S. and Thorvaldsson, V. and Johan Skoog, M. and Hansson, O. and Andreasen, N. and Bogdanovic, N. and others},
  title   = {{Association of IL1RAP-related genetic variation with cerebrospinal fluid concentration of Alzheimer-associated tau protein}},
  journal = {Scientific reports},
  year    = {2019},
  doi     = {10.1038/s41598-018-36650-3},
  pmid    = {30792413},
  url     = {https://doi.org/10.1038/s41598-018-36650-3}
}

@article{groot2022-35649647,
  author  = {Groot, C. and Villeneuve, S. and Smith, R. and Hansson, O. and Ossenkoppele, R.},
  title   = {{Tau PET Imaging in Neurodegenerative Disorders}},
  journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year    = {2022},
  doi     = {10.2967/jnumed.121.263196},
  pmid    = {35649647},
  url     = {https://doi.org/10.2967/jnumed.121.263196}
}

@article{cullen2022-34937781,
  author  = {Cullen, N. and Janelidze, S. and Palmqvist, S. and Stomrud, E. and Mattsson-Carlgren, N. and Hansson, O. and {Alzheimer’s Disease Neuroimaging Initiative}},
  title   = {{Association of CSF Aβ38 Levels With Risk of Alzheimer Disease-Related Decline}},
  journal = {Neurology},
  year    = {2022},
  doi     = {10.1212/wnl.0000000000013228},
  pmid    = {34937781},
  url     = {https://doi.org/10.1212/wnl.0000000000013228}
}

@article{collins2026-42565262,
  author  = {Collins, E. C. and Lu, M. and Beck, R. and Hendrix, J. and Hodsdon, M. E. and Hansson, O.},
  title   = {{Plasma P-tau217 for detecting amyloid clearance after donanemab in Alzheimer's disease}},
  journal = {Alzheimer's \& Dementia},
  year    = {2026},
  doi     = {10.1002/alz.71740},
  pmid    = {42565262},
  url     = {https://doi.org/10.1002/alz.71740}
}

@article{stomrud2010-20142530,
  author  = {Stomrud, E. and Hansson, O. and Zetterberg, H. and Blennow, K. and Minthon, L. and Londos, E.},
  title   = {{Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults}},
  journal = {Archives of neurology},
  year    = {2010},
  doi     = {10.1001/archneurol.2009.316},
  pmid    = {20142530},
  url     = {https://doi.org/10.1001/archneurol.2009.316}
}

@article{henjum2016-27121148,
  author  = {Henjum, K. and Almdahl, I. S. and Årskog, V. and Minthon, L. and Hansson, O. and Fladby, T. and Nilsson, L. N.},
  title   = {{Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2016},
  doi     = {10.1186/s13195-016-0182-1},
  pmid    = {27121148},
  url     = {https://doi.org/10.1186/s13195-016-0182-1}
}

@article{smith2019-30508025,
  author  = {Smith, R. and Wibom, M. and Pawlik, D. and Englund, E. and Hansson, O.},
  title   = {{Correlation of In Vivo [18F]Flortaucipir With Postmortem Alzheimer Disease Tau Pathology}},
  journal = {JAMA neurology},
  year    = {2019},
  doi     = {10.1001/jamaneurol.2018.3692},
  pmid    = {30508025},
  url     = {https://doi.org/10.1001/jamaneurol.2018.3692}
}

@article{lindqvist2013-23911592,
  author  = {Lindqvist, D. and Hall, S. and Surova, Y. and Nielsen, H. M. and Janelidze, S. and Brundin, L. and Hansson, O.},
  title   = {{Cerebrospinal fluid inflammatory markers in Parkinson's disease--associations with depression, fatigue, and cognitive impairment}},
  journal = {Brain, behavior, and immunity},
  year    = {2013},
  doi     = {10.1016/j.bbi.2013.07.007},
  pmid    = {23911592},
  url     = {https://doi.org/10.1016/j.bbi.2013.07.007}
}

@article{demeyer2010-20697045,
  author  = {De Meyer, G. and Shapiro, F. and Vanderstichele, H. and Vanmechelen, E. and Engelborghs, S. and De Deyn, P. P. and Coart, E. and Hansson, O. and others},
  title   = {{Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people}},
  journal = {Archives of neurology},
  year    = {2010},
  doi     = {10.1001/archneurol.2010.179},
  pmid    = {20697045},
  url     = {https://doi.org/10.1001/archneurol.2010.179}
}

@article{kumar2022-35641311,
  author  = {Kumar, A. and Janelidze, S. and Stomrud, E. and Palmqvist, S. and Hansson, O. and Mattsson-Carlgren, N. and {Alzheimer's Disease Neuroimaging Initiative}},
  title   = {{β-Amyloid-Dependent and -Independent Genetic Pathways Regulating CSF Tau Biomarkers in Alzheimer Disease}},
  journal = {Neurology},
  year    = {2022},
  doi     = {10.1212/wnl.0000000000200605},
  pmid    = {35641311},
  url     = {https://doi.org/10.1212/wnl.0000000000200605}
}